Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's … – NASDAQ
Zacks Bull and Bear of the Day Highlights: Eastman Chemical, Kirkland's …NASDAQMeanwhile, Biogen and partner Abbott ( ABT ) moved their MS candidate, daclizumab, into a two-year phase III study (DECIDE) in July 2010. Daclizumab is being evaluated…
